These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1527 related articles for article (PubMed ID: 25928283)

  • 1. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
    Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
    Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I; Stern RS
    Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No end in sight: the skin cancer epidemic continues.
    Donaldson MR; Coldiron BM
    Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.
    Birch-Johansen F; Jensen A; Mortensen L; Olesen AB; Kjær SK
    Int J Cancer; 2010 Nov; 127(9):2190-8. PubMed ID: 20473901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
    Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
    Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and multiplicity rates of keratinocyte cancers in Australia.
    Pandeya N; Olsen CM; Whiteman DC
    Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of nonmelanoma skin cancer incidence rates in kidney transplant recipients in Ireland.
    Bannon FJ; McCaughan JA; Traynor C; O'Brien K; Gavin AT; Maxwell AP; Comber H; Conlon PJ
    Transplantation; 2014 Sep; 98(6):646-52. PubMed ID: 24798309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
    Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
    Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
    JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.
    Halpern AC; Hanson LJ
    Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
    Rudolph C; Schnoor M; Eisemann N; Katalinic A
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.